Antibody may improve plaque psoriasis

A fully human monoclonal antibody that has been found to inhibit interleukin-17A may significantly improve moderate-to-severe plaque psoriasis, according to new phase 2 study data recently released.

Related Videos
Related Content

Dermal Infusions and Injections Lead to Improved Skin Quality

March 31st 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

The Weekly Roundup: March 27-31

March 31st 2023

The Cutaneous Connection- Episode 35: QRPs and the Dermatology Practice

December 2nd 2021

What's Trending in Skin Care: March 2023

March 31st 2023

Treating Dermatological Conditions by Going Beyond the Skin

March 31st 2023

Dermal Infusions and Injections Lead to Improved Skin Quality

March 31st 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

The Weekly Roundup: March 27-31

March 31st 2023

The Cutaneous Connection- Episode 35: QRPs and the Dermatology Practice

December 2nd 2021

What's Trending in Skin Care: March 2023

March 31st 2023

Treating Dermatological Conditions by Going Beyond the Skin

March 31st 2023

Dermal Infusions and Injections Lead to Improved Skin Quality

March 31st 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

The Weekly Roundup: March 27-31

March 31st 2023

The Cutaneous Connection- Episode 35: QRPs and the Dermatology Practice

December 2nd 2021

What's Trending in Skin Care: March 2023

March 31st 2023

Treating Dermatological Conditions by Going Beyond the Skin

March 31st 2023
© 2023 MJH Life Sciences

All rights reserved.